INS and obesity due to melanocortin 4 receptor deficiency: (11) showed that FMT from lean donors to patients with obesity with metabolic syndrome could improve insulin sensitivity in the short to medium term (6 weeks), but no significant difference in the long-term (after 18 weeks).